Skip to main content
. Author manuscript; available in PMC: 2017 Jan 9.
Published in final edited form as: Epidemiol Infect. 2015 Jun 29;144(2):315–324. doi: 10.1017/S0950268815001211

Table 4.

Univariate Risk Factors for Influenza Mortality among American Indian/Alaska Native Persons (alone or in combination with other races), for 5 states (Alaska, Arizona, New Mexico, Oklahoma, Wyoming), 2009.

Risk Factor Level Cases
(n = 32)
Controls
(n = 38)
OR (CI) P-value
Specimen Collection Date April – September, October, November or Later 31% (10) 37% (14)
50% (16) 47% (18) 0.87a
19% (6) 16% (6)

State AK 9% (3) 13% (5)
AZ 16% (5) 5% (2)
NM 41% (13) 18% (7) 0.11
OK 31% (10) 58% (22)
WY 3% (1) 5% (2)

Age Class <18 22% (7) 42% (16) ref 0.13
18–44 34% (11) 34% (13) 1.93 (0.58, 6.40)
45+ 44% (14) 24% (9) 3.56 (1.05, 12.05)

Sex Male 50% (16) 50% (18) ref
Female 50% (16) 50% (18) 1.00 (0.39, 2.59) 1.00

Barrier to Healthcare No 65% (15) 89% (34) ref
Yes 35% (8) 11% (4) 4.53 (1.18, 17.40) 0.03

Household Density ≥ 1.5 Persons/room No 71% (15) 89% (31) ref
Yes 29% (6) 11% (4) 3.10 (0.76, 12.66) 0.12

Wood-Burning Stove No 78% (18) 87% (33) ref
Yes 22% (5) 13% (5) 1.83 (0.47, 7.19) 0.38

≥ 4 Sinks in Household No 77% (17) 61% (22) ref
Yes 23% (5) 39% (14) 0.46 (0.14, 1.54) 0.21

Smoker at Illness Onset No 64% (18) 91% (32) 4.22b (0.99, 18.13) 0.05
Yes 36% (10) 9% (3) 5.93 (1.44, 24.36) 0.01

Secondhand Smoke in Home No 75% (18) 92% (35) ref
Yes 25% (6) 8% (3) 3.89 (0.87, 17.39) 0.08

Heavy Alcohol User No 79% (22) 91% (32) 2.00b (0.44, 9.19) 0.37
Yes 21% (6) 9% (3) 2.91 (0.66, 12.89) 0.16

Obesity No 41% (13) 76% (29) ref
Yes 59% (19) 24% (9) 4.71 (1.69, 13.17) 0.003

Poverty (<$25,000/year) No 35% (6) 74% (23) ref
Yes 65% (11) 26% (8) 5.27 (1.47, 18.94) 0.01

≥ 1 Pre-existing Condition No 31% (10) 69% (24) 5.50b (1.44, 20.96) 0.01
Yes 69% (22) 31% (11) 4.80 (1.71, 13.49) 0.003

Influenza-like illness No 28% (8) 14% (5) ref
Yes 72% (21) 86% (30) 0.44 (0.13, 1.53) 0.19

Antiviral Receipt No 40% (10) 61% (20) ref
Yes (≤ 2 days) 24% (6) 30% (10) 2.31c (0.80, 6.67) 0.12
Yes (≥ 3 days) 36% (9) 9% (3) 5.00d (0.96, 26.11) 0.06

Time from symptom onset to seeking care ≤ 2 days 60% (15) 72% (23) ref
≥ 3 days 40% (10) 28% (9) 1.70 (0.56, 5.17) 0.35
a

test if overall mean specimen date differs between AI/AN cases and controls

b

among those 18 years of age and older

c

comparing those who received antivirals (≤ 2 days and ≥ 3 days combined) to those who did not

d

comparing those who received antivirals ≥ 3 days after symptom onset to those receiving antivirals ≤ 2 days after symptom onset